Sandbox Reserved 1760

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (02:49, 13 December 2022) (edit) (undo)
 
Line 6: Line 6:
== Function of your protein ==
== Function of your protein ==
-
The protein Ornithine Aminotransferase (OAT), in humans (hOAT), is an enzyme that catalyzes the the transfer of an amino group from L-ornithine(L-Orn) to α-ketoglutarate (α-KG). Its ligand, pyridoxal-5'-phosphate (PLP), is a cofactor of this reaction. An amino group from L-Orn is transferred to PLP which converts it to pyridoxamine phosphate (PMP) and L-Orn is converted to L-glutamate-γ-semialdehyde. When the amino group of PMP is transferred to the α-KG, it forms glutamate and regenerates PLP.
+
The protein Ornithine Aminotransferase (OAT), in humans (hOAT), is an enzyme that catalyzes the the transfer of an amino group from L-ornithine(L-Orn) to α-ketoglutarate (α-KG). Its ligand, pyridoxal-5'-phosphate (<scene name='93/934004/Plp/1'>PLP</scene>), is a cofactor of this reaction. An amino group from L-Orn is transferred to PLP which converts it to pyridoxamine phosphate (PMP) and L-Orn is converted to L-glutamate-γ-semialdehyde. When the amino group of PMP is transferred to the α-KG, it forms glutamate and regenerates PLP.
== Biological relevance and broader implications ==
== Biological relevance and broader implications ==
hOAT is found in most tissues in the body but predominates in the liver and kidney. There is a need to study the enzyme hOAT because the overexpression of this protein aids the proliferation of cancer cells, specifically Hepatocellular carcinoma (HCC), a common form of liver cancer. hOAT has been a target for mechanism-based inactivators (MBIs) in ongoing drug design efforts. HCC is normally diagnosed at advanced stages where the tumors tend to be resistant to radiotherapy and chemotherapy, making this type of cancer difficult to treat.
hOAT is found in most tissues in the body but predominates in the liver and kidney. There is a need to study the enzyme hOAT because the overexpression of this protein aids the proliferation of cancer cells, specifically Hepatocellular carcinoma (HCC), a common form of liver cancer. hOAT has been a target for mechanism-based inactivators (MBIs) in ongoing drug design efforts. HCC is normally diagnosed at advanced stages where the tumors tend to be resistant to radiotherapy and chemotherapy, making this type of cancer difficult to treat.

Current revision

This Sandbox is Reserved from November 4, 2022 through January 1, 2023 for use in the course CHEM 351 Biochemistry taught by Bonnie Hall at the Grand View University, Des Moines, USA. This reservation includes Sandbox Reserved 1755 through Sandbox Reserved 1764.
To get started:
  • Click the edit this page tab at the top. Click on Show preview and then Save the page after each step, then edit it again.
  • show the Scene authoring tools, create a molecular scene, and save it. Copy the green link into the page.
  • Add a description of your scene. Use the buttons above the wikitext box for bold, italics, links, headlines, etc.

More help: Help:Editing

Human Ornithine Aminotransferase

Caption for this structure

Drag the structure with the mouse to rotate

References

Butrin A, Butrin A, Wawrzak Z, Moran GR, Liu D. Determination of the pH dependence, substrate specificity, and turnovers of alternative substrates for human ornithine aminotransferase. J Biol Chem. 2022 Jun;298(6):101969. doi: 10.1016/j.jbc.2022.101969. Epub 2022 Apr 20. PMID: 35460691; PMCID: PMC9136103.

Personal tools